We require patients with mild to moderate psoriasis and atopic dermatitis for a new study. This study will be approx. 12 visits to the unit and will spread over approx. 11 weeks. A payment of up to £1350 will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
We require COPD patients for a new study. This study will be approx. 16 visits to the unit and will spread over approx. 6-7 months. A payment of up to £2000 will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience. If you would like to find out more about this study please call our Volunteer Services Team on 0800 655 6553 and quote study MEU 16/335 (Part 2).
We are looking for Healthy volunteers who don’t smoke or take any regular medications and also volunteers with the following conditions: (Asthma, COPD (Chronic Obstructive Pulmonary Disease), Cystic Fibrosis, Dermatitis/ Eczema, Graves’ Disease/ Overactive Thyroid, High Blood Pressure, Psoriasis and any other medical conditions)
We require Cystic Fibrosis patients with the F508del/F508del genotype for a new study. This study will be approx. 9 visits to the unit and will spread over approx. 4-7 weeks.
We require Cystic Fibrosis patients for a new study. This study will be up to 20 visits to the unit and will spread over approx. 8 months.
This study will be approx. 34 visits to the unit and will spread over approx. 9-12 weeks. A payment of up to £2720 will be made on completion of the study for your time, travel expenses and to compensate for any inconvenience.
We require patients with Cystic Fibrosis (CF) for a new study. This study will be approx. 9 visits to the unit and will spread over approx. 4-7 weeks
We require asthmatic patients for a clinical study. This study will be approx. 18 visits to the unit and will spread over approx. 10-11 months.
We require COPD patients for a new study. This study will be approx. 6 visits to the unit and will spread over approx. 18 weeks.
We require patients with Graves’ disease for a new study. This study will be approx. 13 visits to the unit and will spread over approx. 15 to 18 weeks.
A leading specialist clinical research facility working with the pharmaceutical industry to identify potential new treatments for conditions such as Asthma, Bronchitis and Emphysema and now many more therapeutic areas.
We at the MEU want to deliver rewarding research to improve clinical care whilst also rewarding our volunteers for their continued support.
Contact us…
The Medicines Evaluation Unit
The Langley Building
Southmoor Road
Wythenshawe Hospital
Manchester
M23 9QZ
T: 0800 655 6553
E: recruitment@meu.org.uk
